CRISPR Therapeutics (NASDAQ:CRSP) stock has been slowly heading lower in recent months, and I don’t think that’s fair. Having reached highs near $90 a share, the stock is now trading
CRISPR Therapeutics (NASDAQ:CRSP) stock has been slowly heading lower in recent months, and I don’t think that’s fair. Having reached highs near $90 a share, the stock is now trading
The tech landscape is rapidly evolving with the expansion of AI, presenting promising opportunities for semiconductor companies. Adopting a cyclical perspective, Evercore analyst Mark Lipacis, ranked #2 overall by TipRanks
Tesla (NASDAQ:TSLA) is going through a tough patch. On the back of ongoing share losses (40% year-to-date), the stock has hit 52-week lows, with sentiment depressed after Q1 deliveries were
Investing is all about profits and returns – no one puts their money into a stock without an expectation that the investment will make money. The trick is finding the
As the COVID pandemic continues to recede, and as reopened economies continue to bounce back from the pandemic distortions, we are now starting to see the return of normal regional